Abstract
Gene and cell-based therapies (GCTs) have the potential to revolutionize healthcare. Recently, genetically modified T cell products reached the market, which have remarkable clinical benefits for patients with certain blood cancers. However, there are concerns about how to incorporate GCTs into existing regulatory systems for medicinal products. GCTs are different
... read more